Journal Article

Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's Disease Trial

Lon S. Schneider, M. Saleem Ismail, Karen Dagerman, Sonia Davis, Jason Olin, Dennis McManus, Eric Pfeiffer, J. Michael Ryan, David L. Sultzer and Pierre N. Tariot

in Schizophrenia Bulletin

Published on behalf of Maryland Psychiatric Research Center

Volume 29, issue 1, pages 57-72
Published in print January 2003 | ISSN: 0586-7614
Published online January 2003 | e-ISSN: 1745-1701 | DOI: http://dx.doi.org/10.1093/oxfordjournals.schbul.a006991
Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's Disease Trial

More Like This

Show all results sharing this subject:

  • Child and Adolescent Psychiatry

GO

Show Summary Details

Preview

This article describes the development of the protocol for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Alzheimer's disease trial, which was developed in collaboration with the National Institute of Mental Health to assess the effectiveness of atypical antipsychotics for psychosis and/or agitation occurring in outpatients with Alzheimer's disease. The article provides a detailed description of the methodology used in the trial as well as the clinical outcomes and effectiveness measures incorporated into it, discussing the most salient issues encountered in developing the design of the trial, as well as the unique features of the trial.

Keywords: Alzheimer's disease; atypical antipsychotic; psychosis; dementia; effectiveness

Journal Article.  0 words. 

Subjects: Child and Adolescent Psychiatry

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.